A carregar...
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)
BACKGROUND: Hypertriglyceridemia in combination with low HDL cholesterol levels is a risk factor for cardiovascular disease. Our objective was to evaluate the efficacy of ciprofibrate for the treatment of this form of dyslipidemia and to identify factors associated with better treatment response. ME...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2004
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC503398/ https://ncbi.nlm.nih.gov/pubmed/15272932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-3-8 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|